Immunohistochemical and Molecular Characteristics of Follicular Patterned Thyroid Nodules with Incomplete Nuclear Features of Papillary Thyroid Carcinoma.
10.4132/KoreanJPathol.2009.43.6.495
- Author:
Hye Sook MIN
1
;
Gheeyoung CHOE
;
Nam Yun CHO
;
Gyeong Hoon KANG
;
Seong Hoe PARK
;
So Yeon PARK
Author Information
1. Department of Pathology, National Cancer Center, Goyang, Korea. sypmd@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Thyroid gland;
Thyroid neoplasms;
Carcinoma, Papillary
- MeSH:
Adenoma;
Carcinoma;
Carcinoma, Papillary;
Factor IX;
Galectin 3;
Hyperplasia;
Methylation;
Thyroid Gland;
Thyroid Neoplasms;
Thyroid Nodule
- From:Korean Journal of Pathology
2009;43(6):495-502
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Follicular patterned thyroid nodules with incomplete nuclear features of papillary thyroid carcinoma (FTN-INPTCs) are difficult to diagnose, and their biological behavior and association with follicular variants of PTC (FVPTCs) have not yet been established. The aim of this study is to determine immunohistochemical and molecular characteristics of FTN-INPTCs. METHODS: We investigated immunohistochemical features (galectin-3, HBME-1, CK19, fibronectin-1, CITED1), BRAF V600E mutation and RASSF1A promoter methylation status in 30 FTN-INPTC cases, along with 26 FVPTCs, 21 follicular adenomas (FAs) and 14 nodular hyperplasias (NHs). RESULTS: Expression of galectin-3, HBME-1, CK19 and CITED1 was significantly higher in FTN-INPTCs than in FAs or NHs, but expression of galectin-3, CK19 and fibronectin-1 was lower in FTN-INPTCs than in FVPTCs. The BRAF V600E mutation was not detected in the benign nodules or FTN-INPTCs, whereas 57% of FVPTCs had the mutation. RASSF1A promoter methylation was higher in FTN-INPTCs than in benign nodules but there was no difference between FTN-INPTCs and FVPTCs. CONCLUSIONS: Our results represent the borderline immunohistochemical and molecular characteristics of FTN-INPTC. We conclude that FTN-INPTC is an intermediate lesion between a benign nodule and a FVPTC, and that it is pathogenetically related to FVPTC.
